In this section
What is alpha thalassemia?
Thalassemia is an inherited disorder that affects the production of normal hemoglobin (a type of protein in red blood cells that carries oxygen to the tissues of the body). Thalassemia includes a number of different forms of anemia. The severity and type of anemia depends upon the number of genes that are affected.
What causes alpha thalassemia?
Alpha thalassemia is caused by mutations in the alpha chain of the hemoglobin molecule. Normally, there are two alpha chain genes located on each #16 chromosome, for a total of 4. The alpha chain is an important component of fetal hemoglobin (which is usually made before birth) and hemoglobin A and hemoglobin A2 (which are present after birth). How these genes are altered determines the specific type of alpha thalassemia in a child:
- Alpha thalassemia major - all four alpha chain genes are deleted, which is so severe that death can occur in utero (prior to birth).
- Alpha thalassemia carrier - two alpha chain genes are deleted, either: ◦Both from the same #16 chromosome, called a "cis deletion"
- One from both #16 chromosomes, called a "trans deletion"
When parents are carriers of the cis deletion, there is a one in four, or 25 percent, chance with each pregnancy, to have a baby with alpha thal major. Carriers of the cis deletion versus the trans deletion can be distinguished by DNA analysis only. DNA testing is usually done from a blood sample, to look at the alpha chain genes on each #16 chromosome, to determine which are deleted.
- Hemoglobin H disease - three alpha chain genes are deleted. Hemoglobin H disease occurs when a person has only one functioning alpha chain gene, resulting in a hemolytic anemia that can worsen with febrile illness or exposure to certain drugs, chemicals, or infectious agents. Persons with hemoglobin H disease are at increased risk to have a child with alpha thal major, since they carry one #16 chromosome with an alpha chain two gene deletion (cis deletion).
- Silent alpha thalassemia carrier - one alpha chain gene is deleted (the other three are normal). Blood tests are usually normal and the only way to confirm a silent carrier is by DNA studies.
How is alpha thalassemia diagnosed?
The frequency of carriers for alpha thal is about one in 30 in persons who are southeastern Asian or Chinese. The frequency in other populations has not been specifically studied, but is estimated at one in 300. Carrier status can be determined by:
Complete blood count (CBC) - a measurement of size, number and maturity of different blood cells in a specific volume of blood
Hemoglobin electrophoresis with A2 and F quantitation - a lab procedure that differentiates the types of hemoglobin present
FEP (free-erythrocyte protoporphyrin) and ferritin - to exclude iron deficiency anemia
All of these studies can be performed from a single blood sample. Prenatal diagnosis is determined from CVS (chorionic villus sampling) or amniocentesis.
Treatment for alpha thalassemia:
Specific treatment for alpha thalassemia will be determined by your child's physician based on:
Your child's age, overall health and medical history
Extent of the disease
Your child's tolerance for specific medications, procedures or therapies
Expectations for the course of the disease
Your opinion or preference
Treatment for alpha thalassemia may include:
Daily doses of folic acid
Blood transfusions (as needed)
Surgical removal of the spleen (if necessary)
Need more information or an appointment? We’re happy to help.
For appointments, contact the individual programs within our MACC Fund Center for Cancer and Blood Disorders.